LifeMD (LFMD) Shares Outstanding (2012 - 2025)

LifeMD's Shares Outstanding (Entity) history runs 14 years deep, the most recent figure standing at $46.8 million for Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 10.56% year-over-year to $46.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $46.8 million (up 10.56% YoY) and the FY2025 annual result came in at $46.8 million, up 10.56% from the prior year.
• Shares Outstanding (Entity) was $46.8 million for Q4 2025 at LifeMD, roughly flat from $46.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $46.8 million in Q4 2025 and bottomed at $25.9 million in Q1 2021.
• A 5-year average of $36.1 million and a median of $33.7 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) soared 139.04% — and 2022, when it climbed 2.76%.
• LifeMD's Shares Outstanding (Entity) stood at $30.7 million in 2021, then advanced by 2.76% to $31.6 million in 2022, then climbed by 21.57% to $38.4 million in 2023, then climbed by 10.26% to $42.3 million in 2024, then grew by 10.56% to $46.8 million in 2025.
• Business Quant data shows LFMD's Shares Outstanding (Entity) at $46.8 million in Q4 2025, $46.7 million in Q3 2025, and $45.1 million in Q2 2025.